The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis
- 595 Downloads
Despite extensive research on the criteria for the assessment of gastric cancer risk using the Operative Link on Gastritis Assessment (OLGA) and Operative Link on Gastritis/Intestinal-Metaplasia Assessment (OLGIM) systems, no comprehensive overview or systematic summary on their use is currently available.
To perform a systematic review and meta-analysis to assess the efficacy of the OLGA and OLGIM staging systems in evaluating gastric cancer risk.
We searched various databases, including PubMed, EMBASE, Medline, and Cochrane’s library, for articles published before March 2017 on the association between OLGA/OLGIM stages and risk of gastric cancer. Statistical analysis was performed using RevMan 5.30 and Stata 14.0, with the odds ratio, risk ratio, and 95% confidence interval as the effect measures.
A meta-analysis of six case–control studies and two cohort studies, comprising 2700 subjects, was performed. The meta-analysis of prospective case–control studies demonstrated a significant association between the OLGA/OLGIM stages III/IV and gastric cancer. The Newcastle–Ottawa Scale (NOS) score reflected heterogeneity in the case–control studies on OLGA. Subgroup analysis of high-quality (NOS score ≥ 5) studies showed an association between OLGA stage III/IV and increased risk of gastric cancer; the association was also high in the remaining study with low NOS score. The association between higher stages of gastritis defined by OLGA and risk of gastric cancer was significant.
This correlation implies that close and frequent monitoring of such high-risk patients is necessary to facilitate timely diagnosis of gastric cancer.
KeywordsGastric cancer Operative link on gastritis assessment Operative link on gastric intestinal metaplasia assessment stage Risk factors Meta-analysis Systematic review
This study was funded by Natural Science Foundation of China (NSFC) (Grant numbers 81700468 and 81770535).
No ethical approval or informed consent statement was required for this review article.
Conflict of interest
The authors declare that they have no conflict of interest.
- 8.Capelle LG, de Vries AC, Haringsma J, Ter Borg F, de Vries RA, Bruno MJ, van Dekken H, Meijer J, van Grieken NC, Kuipers EJ. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc. 2010;71(7):1150–8.CrossRefPubMedGoogle Scholar
- 11.Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O’Connor A, Pereira C, Pimentel-Nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-Budnik T, Megraud F, Miki K, O’Morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ, European Society of Gastrointestinal Endoscopy; European Helicobacter Study Group; European Society of Pathology; Sociedade Portuguesa de Endoscopia Digestiva. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy. 2012;44(1):74–94.CrossRefPubMedGoogle Scholar
- 12.De Re V, Orzes E, Canzonieri V, Maiero S, Fornasarig M, Alessandrini L, Cervo S, Steffan A, Zanette G, Mazzon C, De Paoli P, Cannizzaro R. Pepsinogens to distinguish patients with gastric intestinal metaplasia and helicobacter pylori infection among populations at risk for gastric cancer. Clin Transl Gastroenterol. 2016;7(7):e183.CrossRefPubMedPubMedCentralGoogle Scholar
- 14.El-Zimaity MH, Riddell RH, Abudayyeh S, Graham YD. Gastric atrophy diagnostic accuracy: comparison of OLGA with Baylor system. Lab Invest. 2009;89:128A.Google Scholar
- 15.Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.CrossRefPubMedGoogle Scholar
- 16.Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P (2009) The New Castle–Ottawa Scale (NOS) for assessing the quality of nonrandomized studies on meta-analysis. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.Accessed 5 Apr 2017.
- 24.Kodama M, Murakami K, Okimoto T, Abe H, Sato R, Ogawa R, Mizukami K, Shiota S, Nakagawa Y, Soma W, Arita T, Fujioka T. Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer. Scand J Gastroenterol. 2013;48(11):1249–56.CrossRefPubMedGoogle Scholar
- 29.Chinese Society of gastroenterology. Chinese national consensus on chronic gastritis. Chin J Gastroenterol. 2017;22(11):670–87.Google Scholar
- 30.Daugule I, Sudraba A, Chiu HM, Funka K, Ivanauskas A, Janciauskas D, Jonaitis L, Kiudelis G, Tolmanis I, Vanags A, Lin JT, Kupcinskas L, Leja M. Gastric plasma biomarkers and operative link for gastritis assessment gastritis stage. Eur J Gastroenterol Hepatol. 2011;23(4):302–7.CrossRefPubMedGoogle Scholar
- 33.Nieminen A, Sipponen P, Kontto J, Puolakkainen P, Virtamo J, Kokkola A. OLGA and OLGIM staging systems in men with atrophic gastritis. United Eur Gastroenterol J. 2015;3(5):A296–7.Google Scholar